Publication | Open Access
A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma
40
Citations
42
References
2014
Year
This new cancer immunotherapy has the potential to be cost-effective and broadly applicable to tumors that overexpress mesothelin.
| Year | Citations | |
|---|---|---|
Page 1
Page 1